Trial Profile
A phase III study of ALG-1001 (Luminate) as an adjunct during pars plana vitrectomy (PPV)
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 01 Aug 2016
Price :
$35
*
At a glance
- Drugs Risuteganib (Primary)
- Indications Retinal disorders
- Focus Therapeutic Use
- 01 Aug 2016 New trial record